COST-EFFECTIVENESS OF DAPTOMYCIN IN PATIENTS WITH INFECTIVE ENDOCARDITIS AND BACTEREMIA CAUSED BY METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS IN TURKEY

被引：0

作者：

Pala, M. ^{[1
]}

Gol, D. ^{[1
]}

机构：

[1] Novartis Turkey, Istanbul, Turkey

来源：

VALUE IN HEALTH | 2010年 / 13卷 / 07期

关键词：

D O I：

10.1016/S1098-3015(11)73301-0

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A550 / A550

页数：1

共 50 条

[1] A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF BACTEREMIA AND INFECTIVE ENDOCARDITIS IN PATIENTS WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTION IN MEXICO
Garcia-Contreras, F.
Revelles, Martinez M.
Briones, B.
VALUE IN HEALTH, 2011, 14 (03) : A118 - A118
[2] Cost-Effectiveness of Daptomycin versus Vancomycin and Gentamicin for Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and/or Endocarditis
Bhavnani, S. M.
Prakhya, A.
Hammel, J. P.
Ambrose, P. G.
CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 691 - 698
[3] COST-EFFECTIVENESS ESTIMATION OF DAPTOMYCIN VS VANCOMYCIN USE IN PATIENTS WITH BACTEREMIA AND/OR ENDOCARDITIS ON S. AUREUS RESISTANT TO METHICILLIN
Paula Micone, P. M.
VALUE IN HEALTH, 2013, 16 (07) : A714 - A714
[4] Cost-Effectiveness Analysis of Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia and Endocarditis Is a Difficult Issue
Westling, Katarina
CLINICAL INFECTIOUS DISEASES, 2009, 49 (05) : 699 - 701
[5] Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis
Ruggero, Michael A.
Peaper, David R.
Topal, Jeffrey E.
INFECTIOUS DISEASES, 2015, 47 (06) : 379 - 384
[6] Bacteremia and infective endocarditis caused by a non-daptomycin-susiceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan
Huang, Yu-Tsung
Hsiao, Cheng-Hsiang
Liao, Chun-Hsing
Lee, Chung-Wei
Hsueh, Po-Ren
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (03) : 1132 - 1136
[7] Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia
Hsu, RB
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (07): : 654 - 657
[8] Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia
Mangili, A
Bica, I
Snydman, DR
Hamera, DH
CLINICAL INFECTIOUS DISEASES, 2005, 40 (07) : 1058 - 1060
[9] Effectiveness of Standard Daptomycin Dose in Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Nair, Rajeshwari
Richardson, Kelly
Livorsi, Daniel
Goto, Michihiko
Perencevich, Eli
Alexander, Bruce
Schweizer, Marin
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2020, 41 : S207 - S208
[10] Maternal Bacteremia Caused by Staphylococcus Aureus With a Focus on Infective Endocarditis
Morelli, Morgan K.
Veve, Michael P.
Shorman, Mahmoud A.
OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (08):

← 1 2 3 4 5 →